Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 1, 2006, Pages 256-264

  McClellan, Sharon A ^a   Huang, Xi ^a   Barrett, Ronald P ^a   Lighvani, Shahrzad ^a   Zhang, Yunfan ^a   Richiert, Dawn ^a   Hazlett, Linda D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; GELATINASE B; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MYELOPEROXIDASE; CHEMOKINE; INTERLEUKIN 1; MIP 2 PROTEIN, MOUSE; MIP-2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KERATITIS; LANGERHANS CELL; MICROARRAY ANALYSIS; MICROSCOPY; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; ZYMOGRAPHY; ANIMAL; ANTIBODY PRODUCTION; BACTERIAL EYE INFECTION; BAGG ALBINO MOUSE; C57BL MOUSE; CORNEA ULCER; DISEASE PREDISPOSITION; DNA MICROARRAY; ENZYMOLOGY; GRAM NEGATIVE INFECTION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; ANTIBODY FORMATION; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; COLLAGEN TYPE IV; CORNEAL ULCER; DISEASE SUSCEPTIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE INFECTIONS, BACTERIAL; FEMALE; IMMUNITY, NATURAL; INTERLEUKIN-1; LANGERHANS CELLS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 33644847774     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1050     Document Type: Article

References (49)

1. Rattanatam T, Heng WJ, Rapuano CJ, et al. Trends in contact lens-related corneal ulcers. Cornea. 2001;20:290-294.
2. Landman D, Quale JM, Mayorga D, et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med. 2002;162:1515-1520.
3. Khatri S, Lass JH, Heinzel FP, et al. Regulation of endotoxin-induced keratitis by PECAM-1, MIP-2 and Toll-like receptor 4. Invest Ophthalmol Vis Sci. 2002;43:2278-2284.
4. Hazlett LD. The corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res. 2004;23:1-30.
5. Gorham JD, Guler ML, Steen RG, et al. Genetic mapping of a murine locus controlling development of T helper1/T helper 2 type responses. Proc Natl Acad Sci USA. 1996;93:12467-12472.
6. Hazlett LD, McClellan SA, Kwon B, Barrett R. Increased severity of P. aeruginosa corneal infection in strains of mice designated as Th1 vs Th2 responsive. Invest Ophthalmol Vis Sci. 2000;41:805-810.
7. Kwon B, Hazlett LD. Association of CD4+ T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection. J Immunol. 1997;159:6283-6290.
8. Hazlett LD, McClellan SA, Rudner XL, Barrett RP. The role of Langerhans cells in Pseudomonas aeruginosa infection. Invest Ophthalmol Vis Sci. 2002;43:189-197.
9. Huang X, Hazlett LD. Analysis of Pseudomonas aeruginosa corneal infection using an oligonucleotide microarray. Invest Ophthalmol Vis Sci. 2003;44:3409-3416.
10. Hazlett LD, McClellan SA, Barrett R, Rudner XL. B7/CD28 costimulation is critical in susceptibility to Pseudomonas aeruginosa corneal infection: a comparative study using monoclonal antibody blockade and CD28-deficient mice. J Immunol. 2001;166:1292-1299.
11. Lighvani, S, Huang, X, Trivedi, PP, et al. Substance P regulates NK cell IFN-γ production and resistance to Pseudomonas aeruginosa infection. Eur J Immunol. 2005;35:1567-1575.
12. Kernacki KA, Fridman R, Hazlett LD, et al. In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infections in naïve and immunized mice. Curr Eye Res. 1997;16:289-297.
13. Kernacki KA, Barrett R, Hazlett LD. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation. Invest Ophthalmol Vis Sci. 1999;40:3168-3176.
14. Dong Z, Katar M, Alousi S, Berk RS. Expression of membrane-type matrix metalloproteinases 4, 5 and 6 in mouse corneas infected with P. aeruginosa. Invest Ophthalmol Vis Sci. 2001;42:3223-3227.
15. Dong Z, Ghabrial M, Katar M, et al. Membrane-type matrix metalloproteinases in mice intracorneally infected with Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci. 2000;41:4189-4194.
16. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem. 1999;274:21491-21494.
17. Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 2001;22:571-579.
18. Hazlett LD, Moon MM, Strejc M, Berk RS. Evidence for N-acetyl-mannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest Ophthalmol Vis Sci. 1987;28:1978-198.
19. Williams RN, Paterson CA, Eakins KE, Bhattacherjee P. Quantification of ocular inflammation: evaluation of polymorphonuclear leucocyte infiltration by measuring myeloperoxidase activity. Curr Eye Res. 1982-83;2:465-470.
20. Hazlett LD, Grevengood C, Berk RS. Change with age in limbal conjunctival epithelial Langerhans cells. Curr Eye Res. 1982-83;2:423-425.
21. Gillette TE, Chandler JW, Greiner JV. Langerhans cells of the ocular surface. Ophthalmology. 1982;89:700-711.
22. Luo Y, Dorf ME. Isolation of mouse neutrophils. Current Protocols in Immunology. New York: John Wiley and Sons; 1997:3.20.1-3.20.6.
23. Hazlett LD, Rosen DD, Berk RS. Pseudomonas eye infections in cyclophosphamide-treated mice. Invest Ophthalmol Vis Sci. 1977;16:649-652.
24. Hazlett LD, Rudner XL, McClellan SA, et al. IL-12 and IFN-γ in Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci. 2002;43:419-424.
25. Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res. 2002;21:1-14.
26. Evanston JM, Jeffrey JJ, Krane SM. Human collagenase: identification and characterization of an enzyme from rheumatoid synovium in culture. Science. 1967;158:499-504.
27. Hyndiuk RA. Experimental Pseudomonas keratitis. Trans Am Ophthalmol. 1981;79:541-624.
28. Hendricks RL, Tumpey TM, Finnegan A. IFN-γ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1 infected mice. J Immunol. 1992;149:3023-3028.
29. Brown SI, Wasserman HE, Dunn MW. Alkali-burn of the cornea. Arch Ophthalmol. 1969;82:91-94.
30. Kenyon KR, Fogle JA, Stone DL, Stark WJ. Regeneration of corneal epithelial basement membrane following thermal cauterization. Invest Ophthalmol Vis Sci. 1977;16:292-301.
31. Hazelman BL, Watson PG. Ocular complications of rheumatoid arthritis. Clin Rheum Dis. 1977;3:501-526.
32. Twining S, Wilson PM, Hatchell DL. Characterization of corneal proteoglycans under vitamin A deficiency. Biochem Biophys Acta. 1989;992:181-190.
33. Miyajima S, Akaike T, Matsumoto K, et al. Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro. Microb Path. 2001;6:271-281.
34. Sakimoto T, Shoji J, Sawa M. Active form of gelatinases in tear fluid in patients with corneal ulcer or ocular burn. Jpn J Ophthalmol. 2003;47:423-426.
35. Claveau I, Mostefaoui Y, Rouabhia M. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans. Matrix Biol. 2004;7:477-486.
36. Lee MM, Yoon B-J, Osiewicz K, et al. Tissue inhibitor of metalloproteinase 1 regulates resistance to infection. Infect Immun. 2005;73:661-665.
37. Noirey N, Staquet MJ, Gariazzo MJ, et al. Relationship between expression of matrix metalloproteinases and migration of epidermal and in vitro generated Langerhans cells. Eur J Cell Biol. 2002;81:383-389.
38. Kobayashi Y. Langerhans' cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens. Immunology. 1997;90:496-501.
39. Kobayashi Y, Matsujoto M, Kotani M, Makino T. Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. J Immunol. 1999;163:5989-5993.
40. D'Haese A, Wuyts A, Dillen C, et al. In vivo neutrophil recruitment by granulocyte chemotactic protein 2 is assisted by gelatinase B/MMP-9 in the mouse. J Interferon Cytokine Res. 2000;20:667-674.
41. Sopata I, Dancewics AM. Presence of a gelatin-specific proteinase and its latent form in human leucocytes. Biochem Biophys Acta. 1974;370:510-523.
42. Mainardi CL, Hibbs MS, Hasty KA, Seyer JM. Purification of a type V collagen degrading metalloproteinase from rabbit alveolar macrophages. Coll Relat Res. 1984;4:479-492.
43. Opendakker G, Masure S, Grillet B, Van Damme J. Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. Lymphokine Cytokine Res. 1991;10:317-324.
44. Opendakker G, Masure S, Proost P, et al. Natural human monocyte gelatinase and its inhibitor. FEBS Lett. 1991;284:73-78.
45. Delcaux C, Delacourt C, D'Ortho MP, et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol. 1996;14:288-295.
46. Betsuyaku T, Shipley JM, Liu Z, Senior RM. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. Am J Respir Cell Mol Biol. 1999;20:1303-1309.
47. Opendakker G, Van den Steen PE, Dubois B, et al. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol. 2001;69:851-859.
48. Rudner XL, Kernacki KA, Barrett RP, Hazlett LD. Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage-inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation. J Immunol. 2000;164:6576-6582.
49. Xue ML, Wakefield D, Willcox MD, et al. Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection. Invest Ophthalmol Vis Sci. 2003;44:2020-2025.